CAS: 891016-02-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide REF: IN-DA01BV7ICAS: 891016-02-7 | 95% | To inquire | Thu 27 Mar 25 |
 | ML-SI3 REF: TM-T9226CAS: 891016-02-7 | 99.75% | 49.00 €~560.00 € | Thu 03 Apr 25 |
 | N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide REF: 3D-RKB01602CAS: 891016-02-7 | Min. 95% | - - - | Discontinued product |
![N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide](https://static.cymitquimica.com/products/IN/thumb/DA01BV7I.jpg)
N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide
CAS:891016-02-7
Formula:
C23H31N3O3S
Purity:
95%
Color and Shape:
Solid
Molecular weight:
429.5755
Ref: IN-DA01BV7I
| 1g | To inquire | ||
| 100mg | 172.00 € | ||
| 250mg | 226.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
ML-SI3
CAS:891016-02-7
CCG-143140 is a GLP-1 receptor inverse agonists.
Formula:
C23H31N3O3S
Purity:
99.75%
Color and Shape:
Solid
Molecular weight:
429.58
Ref: TM-T9226
| 2mg | 49.00 € | ||
| 5mg | 73.00 € | ||
| 10mg | 116.00 € | ||
| 25mg | 235.00 € | ||
| 50mg | 373.00 € | ||
| 100mg | 560.00 € | ||
| 1mL*10mM (DMSO) | 82.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
![N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide](https://static.cymitquimica.com/products/3D/thumb/RKB01602.jpg)
N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide
CAS:891016-02-7
Versatile small molecule scaffold
Formula:
C23H31N3O3S
Purity:
Min. 95%
Molecular weight:
429.6 g/mol
Ref: 3D-RKB01602
| 1g | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
